Navigation Links
Dr. Suwelack Skin & Health Care: New Product in the FDA Certification Process

"We Want to Double our Sales Within Three Years"

BILLERBECK, Germany, October 10 /PRNewswire/ -- With an increase in sales of EUR 3.4 million to EUR 17 million, Dr. Suwelack Skin & Health Care AG is still on the path of significant growth in 2007. "We want to increase our sales to EUR 30 million within three years," states CEO Nikolaus Uleer. With the construction of the largest pharmaceutical-standard production plant in the world, the biotech manufacturer has considerably expanded its activities.

The German biotech manufacturer earns 80 percent of its sales abroad, with the most significant growth in the USA - within one year, its Puracol dressing for chronic wounds has successfully competed against similar products. A second wound dressing is currently undergoing the FDA certification process.

Uleer regards the progress made with the European introduction of the collagen and elastic based biomatrix Matriderm as at least equal in significance to the successes on the US market. Surgeons implant Matriderm as a dermis replacement for the treatment of deep burn wounds. Says Uleer: "With an equity to assets ratio of 70 percent, the company is well-prepared for the international introduction of other medical products."

However: About 80 percent of international sales are in the cosmetics sector. International cosmetics companies implement their facial mask systems, and the major consumers are in Japan, Hong Kong and Germany. Regarding the objectives, Uleer explains: "Our product expertise has not yet been generally recognized, but we are seriously working on this. We intend to gain synergies from the latest scientific research in the medical and cosmetics fields and use these for product development."

Press contact:


Claudia-Maria Rohrer

Grossbeerenstrasse 28 c

10965 Berlin, Germany

Tel.: +49-30-887102-18

Fax: +49-30-887102-22


SOURCE Dr. Suwelack Skin & Health Care AG
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
2. Web-based reporting credited with states top healthcare ranking
3. Visions, Part II: Preizler sees IT leading incremental health system change
4. Visions: Preizler offers insurers perspective on healthcare IT
5. Federal bill would set healthcare IT standards
6. IRS ruling could speed healthcare technology adoption
7. Bill would provide federal aid for healthcare IT
8. Cardinal Health likes growth potential of Viasys NeuroCare Group
9. DHC 2007: Controlling health IT costs the key to capturing value
10. Siemens health services president calls IT benefits unassailable
11. DHC 2007: Without fuller IT adoption, health costs might drain Americas wealth
Post Your Comments:
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology:
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... , November 17, 2015 ... au 19 novembre  2015.  --> Paris ... --> DERMALOG, le leader de l,innovation biométrique, ... la fois passeports et empreintes sur la même surface ... les passeports et l,autre pour les empreintes digitales. Désormais, ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
Breaking Biology News(10 mins):